Published in Hepatology on June 01, 2004
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93
Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87
Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84
Recent trends in the endoscopic management of variceal bleeding in children. Pediatr Gastroenterol Hepatol Nutr (2013) 0.81
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
Endoscopic management of esophageal varices. World J Gastrointest Endosc (2012) 0.81
Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol (2014) 0.79
Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol (2010) 0.77
Predictors of mortality within 6 weeks after treatment of gastric variceal bleeding in cirrhotic patients. Medicine (Baltimore) (2014) 0.76
Endoscopic management of portal hypertension. Int J Hepatol (2012) 0.76
Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial. J Clin Exp Hepatol (2015) 0.75
Changes in Cardiac Varices and Their Clinical Significance after Eradication of Esophageal Varices by Band Ligation. Can J Gastroenterol Hepatol (2016) 0.75
Role of endoscopy in management of gastrointestinal complications of portal hypertension. World J Gastrointest Endosc (2015) 0.75
Measurement of hepatic venous pressure gradient in patients with active variceal bleeding. Hepatology (2005) 0.75
Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation: A Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.75
Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis. Int J Clin Exp Med (2015) 0.75
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol (2006) 3.65
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int (2011) 2.77
Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol (2005) 2.07
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol (2010) 1.93
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology (2008) 1.81
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection. Am J Gastroenterol (2004) 1.71
Bowel preparation increases the diagnostic yield of capsule endoscopy: a prospective, randomized, controlled study. Gastrointest Endosc (2004) 1.64
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe? Hepatology (2006) 1.53
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology (2005) 1.46
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet Infect Dis (2007) 1.40
Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt. Transplantation (2006) 1.40
Intracerebral hemorrhage after therapeutic upper-GI endoscopy: report of a case. Gastrointest Endosc (2006) 1.38
Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol (2012) 1.17
Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol (2002) 1.16
Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial. Scand J Gastroenterol (2005) 1.02
Gastrointestinal and liver side effects of drugs in elderly patients. Best Pract Res Clin Gastroenterol (2010) 0.99
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antivir Ther (2007) 0.99
Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease. J Clin Gastroenterol (2010) 0.97
Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Invest (2011) 0.94
Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc (2002) 0.94
High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity. Eur J Gastroenterol Hepatol (2007) 0.93
Current treatment indications and strategies in chronic hepatitis B virus infection. World J Gastroenterol (2008) 0.93
EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. J Hepatol (2009) 0.93
Long-term acid suppressive therapy may prevent the relapse of lower esophageal (Schatzki's) rings: a prospective, randomized, placebo-controlled study. Am J Gastroenterol (2005) 0.90
Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol (2009) 0.90
Ultrasound-guided liver biopsy in real life: comparison of same-day prebiopsy versus real-time ultrasound approach. J Gastroenterol Hepatol (2007) 0.89
Endoscopic extraction of large common bile duct stones: A review article. World J Gastrointest Endosc (2012) 0.89
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. J Hepatol (2009) 0.89
Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention. Gastrointest Endosc (2009) 0.89
Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL). Ann Hepatol (2010) 0.88
Acceptance of hepatitis B vaccination among health care workers in Western Greece. Arch Environ Occup Health (2014) 0.87
MELD is not enough--enough of MELD? J Hepatol (2005) 0.87
Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scand J Gastroenterol (2009) 0.86
Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit. Ann Hepatol (2013) 0.86
A prospective cross-over study using a sphincterotome and a guidewire to increase the success rate of common bile duct cannulation. World J Gastroenterol (2005) 0.85
Biliary tract malignancy and abnormal pancreaticobiliary junction in a Western population. J Gastroenterol Hepatol (2007) 0.85
A rare etiology of post-endoscopic retrograde cholangiopancreatography pneumoperitoneum. World J Gastroenterol (2008) 0.84
Clearing the stomach before emergency endoscopy in cirrhotics with acute upper gastrointestinal bleeding. A gastrokinetic or a vasoactive drug? J Hepatol (2003) 0.84
Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine. J Clin Microbiol (2013) 0.83
Wireless capsule endoscopy versus enteroclysis in the diagnosis of small-bowel Crohn's disease. Eur J Gastroenterol Hepatol (2009) 0.83
Monolobar Caroli's disease complicated by cholangiocarcinoma in a 70-year-old man, previously asymptomatic. Gastrointest Endosc (2004) 0.82
Rheumatic manifestations of hepatitis. Curr Opin Rheumatol (2010) 0.81
Prevalence and axial length of hiatus hernia in patients, with nonerosive reflux disease: a prospective study. J Clin Gastroenterol (2007) 0.81
Interferon-alpha plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B. World J Gastroenterol (2005) 0.80
Primary prevention of variceal haemorrhage: a pharmacological approach. J Hepatol (2010) 0.80
Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment. J Clin Rheumatol (2010) 0.80
The relationship between liver function and portal pressure: what comes first, the chicken or the egg? J Hepatol (2005) 0.80
Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci (2013) 0.80
Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis? Hepatology (2011) 0.80
Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system. Am J Gastroenterol (2009) 0.80
Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur J Haematol (2006) 0.79
Prenatal diagnosis of a cervical teratoma with a cytogenetic study. J Matern Fetal Neonatal Med (2006) 0.79
Cronkhite-Canada syndrome associated with a giant cell bone tumor. J Gastrointestin Liver Dis (2012) 0.79
Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn. Eur J Gastroenterol Hepatol (2013) 0.79
Management of varices in cirrhosis. Expert Opin Pharmacother (2011) 0.79
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients. Liver Int (2014) 0.78
Adiposity factors are not related to the presence of colorectal adenomas. Clin Exp Gastroenterol (2011) 0.78
The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol (2013) 0.77
Effects of endoscopic variceal treatment on oesophageal function: a prospective, randomized study. Eur J Gastroenterol Hepatol (2002) 0.77
Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance. Eur J Gastroenterol Hepatol (2009) 0.77
Variceal bleeding in primary biliary cirrhosis patients: a subgroup with improved prognosis and a model to predict survival after first bleeding. Eur J Gastroenterol Hepatol (2009) 0.77
Recent advances in cirrhotic cardiomyopathy. Dig Dis Sci (2014) 0.77
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy. Biomed Res Int (2013) 0.77
Toxic hepatitis after sequential administration of flutamide and cyproterone acetate. Dig Dis Sci (2004) 0.77
Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece. Eur J Gastroenterol Hepatol (2013) 0.77
Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. Eur J Gastroenterol Hepatol (2015) 0.77
Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study. J Gastroenterol Hepatol (2007) 0.77
Sclerotherapy versus vasoactive drugs: are all meta-analyses the same? Gastroenterology (2004) 0.76
Early increase of lower oesophageal sphincter pressure after band ligation of oesophageal varices in cirrhotics: an intriguing phenomenon. Eur J Gastroenterol Hepatol (2002) 0.76
Combined use of metallic endoclips and endoloops using a single-channel scope in closing iatrogenic perforations and fistulas: two case reports and a literature review. Eur J Gastroenterol Hepatol (2014) 0.76
Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection. Hepatology (2007) 0.75
Antiviral therapy for recurrent hepatitis C infection after liver transplantation. Transplantation (2005) 0.75
Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load. Eur J Gastroenterol Hepatol (2011) 0.75
Elastography for hepatic fibrosis severity in chronic hepatitis B or C. Case Rep Gastroenterol (2011) 0.75
Long-term prognosis of cirrhotics with an upper gastrointestinal bleeding episode: does infection play a role? J Gastroenterol Hepatol (2008) 0.75
Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes. Eur J Haematol (2005) 0.75
Sexual functioning in patients with chronic hepatitis C: a systematic review. Eur J Gastroenterol Hepatol (2017) 0.75
Superficial venous thrombophlebitis associated with pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B. J Gastrointestin Liver Dis (2012) 0.75
Fibrous ring formation in cirrhotics treated with band ligation. Hepatogastroenterology (2008) 0.75